普瑞巴林与利马前列素治疗腰椎管狭窄症疗效比较:前瞻性随机对照试验
本研究为前瞻性、随机、单中心、单盲、临床优效性试验,纳入腰椎管狭窄症患者,每组111例,分别接受普瑞巴林或利马前列素标准方案治疗6周。结果显示两组在背痛和腿痛VAS、ODI、EQ-5D及睡眠质量上均随时间显著改善,但组间无显著差异;作者建议根据个体药物反应和潜在并发症选择用药。
要点
- 两组背痛和腿痛VAS均随时间显著改善,但组间无显著差异。
- 两组ODI和EQ-5D均显著改善,但组间无显著差异。
- 睡眠差(PSQI>5)亚组中两组睡眠质量均显著改善,组间无显著差异。
核心结论
- 普瑞巴林与利马前列素在背痛、腿痛、ODI、EQ-5D及睡眠质量方面均有效,但两组间无显著差异。
- 作者建议根据个体药物反应和潜在并发症选择用药。
研究设计与样本
- 前瞻性、随机、单中心、单盲、临床优效性试验, targeting 腰椎管狭窄症患者。
- 每组111例患者,治疗6周,按标准方案给药,之后测量患者报告结局。
主要发现
- 治疗6周后,两组背痛和腿痛VAS均随时间显著改善,但组间无显著差异。
- 两组ODI和EQ-5D均显著改善,但组间无显著差异。
- 在睡眠差(PSQI>5)亚组中,两组睡眠质量均显著改善,但组间无显著差异。
关键数值与推荐
- 主要结局为背痛和腿痛视觉模拟评分(VAS)。
- 次要结局包括Oswestry功能障碍指数(ODI)、欧洲五维健康量表(EQ-5D)和睡眠质量。
- 睡眠差亚组定义为匹兹堡睡眠质量指数(PSQI)>5。
临床怎么用
- 作者认为,可根据个体药物反应和潜在并发症选择普瑞巴林或利马前列素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with Lumbar Spinal Stenosis (LSS) typically complain of back pain and leg pain. These symptoms reduce the quality of life (QoL) and also cause sleep disturbances. This study compares pregabalin and limaprost's efficacy in LSS for pain, disability, QoL, and sleep, aiming to offer insights for medication selection. METHODS: This study was designed as a prospective, randomized, single-center, single-blinded, clinical superiority trial targeting patients with LSS. For 6 weeks, 111 patients per group were administered medication following a standard regimen, after which patient-reported outcomes were measured. The primary outcome was the Visual Analogue Scale (VAS) for back and leg pain, and the secondary outcomes included the Oswestry Disability Index (ODI), European Quality of Life 5 Dimensions (EQ-5D), and sleep quality. RESULTS: After 6 weeks of medication, there were significant improvements over time in the primary outcome, VAS for back pain and leg pain, in both groups, but no significant difference between the 2 groups. Similarly, for the secondary outcomes, ODI and EQ-5D, both groups showed significant improvements, yet there was no significant difference between them. In the subgroup analysis targeting poor sleepers (Pittsburgh sleep quality index, PSQI >5), both groups also exhibited significant improvements in sleep quality, but again, there was no significant difference between the groups. CONCLUSIONS: Efficacy of pregabalin, limaprost in back and leg pain, ODI, EQ-5D, and sleep quality, but there was no significant difference between the 2 groups. Thus, it is advisable to prescribe based on individual drug responses and potential complications.
引用
- Park JH, Yeom JS, Park SM, et al. Comparative Study on the Efficacy of Pregabalin Versus Limaprost in Patients With Lumbar Spinal Stenosis: A Prospective, Randomized Controlled Trial. World Neurosurg. 2024. PMID: 38608818. doi:10.1016/j.wneu.2024.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。